Market Tracker

05/02 6:45pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

3.65
Delayed Data
As of 4:00pm ET
 -0.12 / -3.18%
Today’s Change
2.58
Today|||52-Week Range
6.85
+3.11%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close3.77
Today’s open3.76
Day’s range3.53 - 3.78
Volume1,698,054
Average volume (3 months)2,276,765
Market cap$622.5M
Dividend yield5.48%
Data as of 4:00pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-67.32%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.66%
P/E ratio1.8
Price/Sales0.99
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.19-1.16%
CPXXCelator Pharmaceutic...+0.22+1.46%
SRPTSarepta Therapeutics...+3.73+26.29%
EPZMEpizyme Inc+0.25+2.40%
Data as of 4:00pm ET, 05/02/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.50
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts